News | April 13, 2009

Abstracts for WMIC 2009 Due in May

April 14, 2009 - Abstract submissions are due on May 11, 2009, for the World Molecular Imaging Congress (WMIC 2009), which will be held from Sep. 23-26 in Montreal.

The current rate of submission suggests that WMIC 2009 will receive more abstracts than for WMIC 2008. The group is using a new submission system, Abstract Central, a ScholarOne product.

Abstract Central is configured to collect disclosures of financial relationships directly from each co-author. Every co-author will receive an email urging them to access the system and complete their disclosures. All co-authors are required complete their disclosures in order for an abstract to be accepted for presentation.

Abstract Central is designed to enable affiliation consistency and accuracy by requiring the submitting author to create affiliations first and then to add authors, selecting the proper affiliation for each author.

WMIC 2009 has arranged for Abstract Central to create an account for each submitting author who participated in previous WMIC, JMIC or SMI.
WMIC 2009 will embrace all aspects of molecular imaging, and, except for the first day's Educational Sessions, the program will be constructed almost entirely on the strength of submitted abstracts.

For more information: http://wmicmeeting.org/dev/

Related Content

Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages